Reimagine Care and Dan Nardi scale CAR-T programs with remote cancer care, AI triage and nurses, as the Cureety partnership tackles staffing and access.
News|Articles|January 16, 2025
- MHE January 2025
- Volume 35
- Issue 1
Telehealth, the Fully Hybridized Version | Prediction for 2025
Author(s)Lyle Berkowitz, M.D
Lyle Berkowitz, M.D., CEO of KeyCare, gives a prediction for 2025.
Advertisement
The 1.0 era of isolated telehealth is finally dead. We’re thrilled to welcome the new era of connected telehealth. In this new hybrid approach, telehealth services will be fully coordinated with health systems, providing patients with seamless experiences and full data sharing to enable increased access to high-quality care.
Articles in this issue
over 1 year ago
Lab Power | Predictions for 2025over 1 year ago
Here we are Now, Enable us | Predictions for 2025over 1 year ago
Cybersecurity on Health Plan Radar | Predictions for 2025over 1 year ago
Simulacra of Data as an Answer | Predictions for 2025over 1 year ago
AI Soups up Payer Operations | Predictions for 2025over 1 year ago
Digital Lifeline | Predictions for 2025over 1 year ago
Show us Your Prices | Predictions for 2025Advertisement
Related to this article
Biosimilars can cost $600 a month versus $6,000 for branded rivals, but PBM rebate incentives push formularies toward pricier drugs, says Christine Johnston.
Dan Nardi shares how Reimagine Care uses AI triage and connected devices to scale outpatient cancer support, enabling faster, personalized symptom monitoring.
In this interview, Jordan Herring, Ph.D., and Carlos E. Rodriguez-Diaz, Ph.D., MPHE, MCHES, discuss their study, which found a 16.8% increase in HIV incidence rates among Hispanic populations in antisanctuary counties after 2018 immigration policy shifts.
Metabolic dysfunction-associated steatotic liver disease (MASLD) may differ biologically from obesity-linked MASH, a mouse study suggests, with salt driving liver inflammation without obesity.
In this discussion, Ohio State economist Eric Seiber, Ph.D., explains how inconsistent claims-data definitions can skew estimates of first-episode psychosis and why standardization matters for early treatment and sustainable payment models.
CMS’ mandatory GLOBE drug model ties some Medicare Part B rebates to global prices, but cuts projected savings sharply amid shifting Part D premiums.
Bill Kerr of Avalon Heath Solutions says incorporating Z codes into CPT codes for lab and genetic testing would add needed specificity, reduce waste and possibly head off fraud.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Billing for lab tests, especially genetic tests, is a mess. Bill Kerr has ideas about how to clean it up.
2
A conversation with Jordan Herring, Ph.D., and Carlos E. Rodriguez-Diaz, Ph.D., MPHE, MCHES, about the relationship between HIV incidence in Hispanic communities and immigration policy
3
Final GLOBE drug model projects much smaller savings while 2027 Part D premiums split
4
Closing the outpatient monitoring gap in cancer
5